• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃食管反流病在间质性肺疾病相关住院患者中的预后价值。

The prognostic value of gastroesophageal reflux disorder in interstitial lung disease related hospitalizations.

机构信息

Department of Pulmonary and Critical Care Medicine, East Carolina University, Greenville, NC, USA.

Department of Bioinformatics and Biostatistics, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, USA.

出版信息

Respir Res. 2023 Mar 30;24(1):97. doi: 10.1186/s12931-023-02407-4.

DOI:10.1186/s12931-023-02407-4
PMID:36998050
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10061884/
Abstract

BACKGROUND

Gastroesophageal reflux disease (GERD) is a common comorbidity in patients with interstitial lung disease (ILD). We built and validated a model using the national inpatient sample (NIS) database to assess the contributory role of GERD in ILD-related hospitalizations mortality.

METHODS

In this retrospective analysis, we extracted ILD-related hospitalizations data between 2007 and 2019 from the NIS database. Univariable logistic regression was used for predictor selection. Data were split into the training and validation cohorts (0.6 and 0.4, respectively). We used decision tree analysis (classification and regression tree, CART) to create a predictive model to explore the role of GERD in ILD-related hospitalizations mortality. Different metrics were used to evaluate our model. A bootstrap-based technique was implemented to balance our training data outcome to improve our model metrics in the validation cohort. We conducted a variance-based sensitivity analysis to evaluate GERD's importance in our model.

FINDINGS

The model had a sensitivity of 73.43%, specificity of 66.15%, precision of 0.27, negative predictive value (NPV) of 93.62%, accuracy of 67.2%, Matthews Correlation Coefficient (MCC) of 0.3, F1 score of 0.4, and area under the curve (AUC) for the receiver operating characteristic (ROC) curve of 0.76. GERD did not predict survival in our cohort. GERD contribution to the model was ranked the eleventh among twenty-nine variables included in this analysis (importance of 0.003, normalized importance of 5%). GERD was the best predictor in ILD-related hospitalizations who didn't receive mechanical ventilation.

INTERPRETATIONS

GERD is associated with mild ILD-related hospitalization. Our model-performance measures suggest overall an acceptable discrimination. Our model showed that GERD does not have a prognostic value in ILD-related hospitalization, indicating that GERD per se might not have any impact on mortality in hospitalized ILD patients.

摘要

背景

胃食管反流病(GERD)是间质性肺疾病(ILD)患者常见的合并症。我们使用国家住院患者样本(NIS)数据库构建并验证了一个模型,以评估 GERD 在ILD 相关住院死亡率中的作用。

方法

在这项回顾性分析中,我们从 NIS 数据库中提取了 2007 年至 2019 年间与 ILD 相关的住院数据。使用单变量逻辑回归进行预测因子选择。数据分为训练和验证队列(分别为 0.6 和 0.4)。我们使用决策树分析(分类和回归树,CART)创建预测模型,以探讨 GERD 在 ILD 相关住院死亡率中的作用。使用不同的指标来评估我们的模型。实施基于引导的技术来平衡我们的训练数据结果,以提高我们在验证队列中的模型指标。我们进行了基于方差的敏感性分析,以评估 GERD 在我们模型中的重要性。

结果

该模型的灵敏度为 73.43%,特异性为 66.15%,精度为 0.27,阴性预测值(NPV)为 93.62%,准确性为 67.2%,马修斯相关系数(MCC)为 0.3,F1 得分为 0.4,接收器操作特征(ROC)曲线下面积(AUC)为 0.76。在我们的队列中,GERD 并不能预测生存。在这项分析中包含的 29 个变量中,GERD 对模型的贡献排名第 11(重要性为 0.003,归一化重要性为 5%)。在未接受机械通气的 ILD 相关住院患者中,GERD 是最好的预测因子。

解释

GERD 与轻度 ILD 相关的住院有关。我们的模型性能指标表明总体上具有可接受的区分能力。我们的模型表明,GERD 在 ILD 相关住院中没有预后价值,这表明 GERD 本身可能不会对住院ILD 患者的死亡率产生任何影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a84c/10061884/7591fb617e7f/12931_2023_2407_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a84c/10061884/bbc6fbd32b0d/12931_2023_2407_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a84c/10061884/221c991017a5/12931_2023_2407_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a84c/10061884/7591fb617e7f/12931_2023_2407_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a84c/10061884/bbc6fbd32b0d/12931_2023_2407_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a84c/10061884/221c991017a5/12931_2023_2407_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a84c/10061884/7591fb617e7f/12931_2023_2407_Fig3_HTML.jpg

相似文献

1
The prognostic value of gastroesophageal reflux disorder in interstitial lung disease related hospitalizations.胃食管反流病在间质性肺疾病相关住院患者中的预后价值。
Respir Res. 2023 Mar 30;24(1):97. doi: 10.1186/s12931-023-02407-4.
2
Interstitial lung disease and gastroesophageal reflux disease: key role of esophageal function tests in the diagnosis and treatment.间质性肺疾病与胃食管反流病:食管功能测试在诊断和治疗中的关键作用
Arq Gastroenterol. 2011 Apr-Jun;48(2):91-7. doi: 10.1590/s0004-28032011000200002.
3
Assessment of interstitial lung disease among black rheumatoid arthritis patients.评估黑人类风湿关节炎患者的间质性肺病。
Clin Rheumatol. 2019 Dec;38(12):3413-3424. doi: 10.1007/s10067-019-04760-6. Epub 2019 Aug 30.
4
Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases.急性呼吸住院的病因可预测肺纤维化性间质性肺疾病的存活率。
PLoS One. 2020 Nov 30;15(11):e0242860. doi: 10.1371/journal.pone.0242860. eCollection 2020.
5
Costs of Pharmacological and Non-Pharmacological Interventions in Interstitial Lung Disease Management in Germany.德国间质性肺病管理中药物和非药物干预的成本。
Respiration. 2022;101(11):1015-1023. doi: 10.1159/000526575. Epub 2022 Oct 27.
6
Trends and seasonal variation of hospitalization and mortality of interstitial lung disease in the United States from 2006 to 2016.2006 年至 2016 年美国间质性肺疾病住院和死亡率的趋势和季节性变化。
Respir Res. 2020 Jun 16;21(1):152. doi: 10.1186/s12931-020-01421-0.
7
Idiopathic pulmonary fibrosis and gastroesophageal reflux disease: A population-based, case-control study.特发性肺纤维化与胃食管反流病:基于人群的病例对照研究。
Respir Med. 2021 Mar;178:106309. doi: 10.1016/j.rmed.2021.106309. Epub 2021 Jan 22.
8
Characteristics of gastroesophageal reflux disease in children with interstitial lung disease.儿童间质性肺疾病伴胃食管反流病的特点。
Pediatr Pulmonol. 2023 Jan;58(1):171-177. doi: 10.1002/ppul.26176. Epub 2022 Oct 11.
9
Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care.疾病经济负担:特发性肺纤维化(ILD)和合并症对医疗费用的影响
Respir Med. 2019 Jun;152:25-31. doi: 10.1016/j.rmed.2019.04.009. Epub 2019 Apr 22.
10
Interstitial Lung Disease: Seasonality of Hospitalizations and In-Hospital Mortality 2005-2015.间质性肺疾病:2005-2015 年住院和院内死亡率的季节性。
Respiration. 2022;101(3):253-261. doi: 10.1159/000519214. Epub 2021 Oct 8.

引用本文的文献

1
Risk factors for progression of pulmonary fibrosis: a single-centered, retrospective study.肺纤维化进展的危险因素:一项单中心回顾性研究。
Front Med (Lausanne). 2024 Feb 7;11:1335758. doi: 10.3389/fmed.2024.1335758. eCollection 2024.
2
Biomarkers in Systemic Sclerosis: An Overview.系统性硬化症中的生物标志物:概述
Curr Issues Mol Biol. 2023 Sep 25;45(10):7775-7802. doi: 10.3390/cimb45100490.

本文引用的文献

1
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?特发性肺纤维化中的胃食管反流病:旁观者还是参与者?治疗还是不治疗?
Pharmaceuticals (Basel). 2022 Aug 22;15(8):1033. doi: 10.3390/ph15081033.
2
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化(更新版)和成人进展性肺纤维化:美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST.
3
Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis.
进行性纤维化间质性肺病的蛋白质组学生物标志物:一项多中心队列分析。
Lancet Respir Med. 2022 Jun;10(6):593-602. doi: 10.1016/S2213-2600(21)00503-8. Epub 2022 Jan 18.
4
National Temporal Trends in Hospitalization and Inpatient Mortality in Patients With Pulmonary Sarcoidosis in the United States Between 2007 and 2018.2007年至2018年美国肺结节病患者住院治疗及住院死亡率的全国时间趋势
Chest. 2022 Jan;161(1):152-168. doi: 10.1016/j.chest.2021.07.2166. Epub 2021 Aug 5.
5
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19.胸部 CT 在解读肺间质受累中的作用:系统性硬化症与 COVID-19。
Rheumatology (Oxford). 2022 Apr 11;61(4):1600-1609. doi: 10.1093/rheumatology/keab615.
6
Global incidence and prevalence of idiopathic pulmonary fibrosis.特发性肺纤维化的全球发病率和患病率。
Respir Res. 2021 Jul 7;22(1):197. doi: 10.1186/s12931-021-01791-z.
7
Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations.结缔组织病相关性间质性肺疾病:一种常见病变,具有多种发病机制和治疗策略。
Front Immunol. 2021 Jun 7;12:684699. doi: 10.3389/fimmu.2021.684699. eCollection 2021.
8
Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management.特发性肺纤维化的肺部以外表现:了解疾病机制以改善诊断和管理。
Respir Res. 2021 Apr 17;22(1):109. doi: 10.1186/s12931-021-01711-1.
9
Patients With Idiopathic Pulmonary Fibrosis Admitted to the ICU With Acute Respiratory Failure-A Reevaluation of the Risk Factors and Outcomes.特发性肺纤维化患者因急性呼吸衰竭入住 ICU-危险因素和结局的再评估。
J Intensive Care Med. 2022 Mar;37(3):342-351. doi: 10.1177/0885066621989244. Epub 2021 Jan 29.
10
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease.基于聚类的分析评估纤维化间质性肺疾病合并症的影响。
Respir Res. 2020 Dec 7;21(1):322. doi: 10.1186/s12931-020-01579-7.